Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://doi.org/10.1007/978-3-642-67770-0_1 below:

Chemistry of Psychotomimetics | SpringerLink

• Abood, L.G.: The psychotomimetic glycolate esters. In: Drugs affecting the central nervous system. Burger, A. (ed.), pp. 127–167. New York: Marcel Decker 1968

  Google Scholar 

• Abood, L.G., Biel, J.H., Ostfeld, A.M.: The psychotogenic effects of some N-substituted piperidyl benzilates. In: Neuropsychopharmacology. Bradley, P.B., Deniker, P., Radouco- Thomas, C. (eds.), pp. 433–438. Amsterdam: Elsevier 1959a

  Google Scholar 

• Abood, L.G., Ostfeld, A.M., Biel, J.H.: Structure-activity relationships of 3-piperidyl benzilates with psychotogenic properties. Arch. Int. Pharmacodyn. Ther. 120, 185–200 (1959b)

  Google Scholar 

• Abramson, H.A.: Lysergic acid diethylamide (LSD-25): XXIX. The response index as a measure of threshold activity of psychotropic drugs in man. J. Psychol. 48, 65–78 (1959)

  Article  CAS  Google Scholar 

• Abramson, H.A., Rolo, A.: Comparison of LSD with methysergide and psilocybin on test subjects. In: The use of LSD in psychotherapy and alcoholism. Abramson, H.A. (ed.), pp. 55–73. New York, Bobs-Merrill 1967

  Google Scholar 

• Adams, R.: Marihuana. Harvey Lect., Sers. 37, 168–197 (1942)

  Google Scholar 

• Agurell, S., Holmstedt, B., Lindgren, J.-E.: Alkaloid content of Banisteriopsis rusbyana (Ndz.) Morton. Am. J. Pharm. 140, 148–151 (1968)

  PubMed  CAS  Google Scholar 

• Aldous, F.A.B., Barrass, B.C., Brewster, K., Buxton, D.A., Green, D.M., Pinder, R.M., Rich, P., Skeels, M., Tutt, K.J.: Structure-activity relationships in psychotomimetic phenylalkyl- amines. J. Med. Chem. 77, 1100–1111 (1974)

  Article  Google Scholar 

• Alles, G.A.: Some relations between chemical structure and physiological action of mescaline and related compounds. In: Neuropharmacology, Trans. Fourth Conf. Abramson, H.A. (ed.), pp. 181–268. J. Macy Jr. Foundation, 1959

  Google Scholar 

• Anderson, G.M. III, Braun, G., Braun, U., Nichols, D.E., Shulgin, A.T.: Absolute configuration and psychotomimetic activity. QuaSAR Research Monograph No. 22. Barnett, G., Trsic, M., Willette, R. (eds.), pp. 8-15. National Institute on Drug Abuse, U.S.G.P.O. 1978

  Google Scholar 

• Asatoor, A.M., Dalgleish, C.F.: Amines in blood and urine. Biochem. J. 73, 26P (only) 1959

  Google Scholar 

• Baker, R.W., Chothia, C., Pauling, P., Weber, H.P.: Molecular structures of hallucinogenic stubstances: Lysergic acid diethylamide, psilocybin and 2,4,5-trimethoxyamphetamine. Mol. Pharmacol. 9, 23–32 (1973)

  PubMed  CAS  Google Scholar 

• Barfknecht, C.F., Nichols, D.E., Dunn, W.J.: Correlation of psychotomimetic activity of phenethylamines and amphetamines with 1-octanol-water partition coefficients. J. Med. Chem. 18, 208–210 (1975)

  Article  PubMed  CAS  Google Scholar 

• Benington, F., Morin, R.D., Clark, L.C., Fox, R.P.: Psychopharmacological activity of ring- and side chain-substituted beta-phenethylamines. J. Org. Chem. 23, 1979–1984 (1958)

  Article  CAS  Google Scholar 

• Beringer, K.: Der Meskalinrausch, seine Geschichte und Erscheinungsweise, S. 1–315. Berlin: J. Springer 1927

  Google Scholar 

• Bigwood, J., Ott, J., Thompson, C., Neely, P.: Entheogenic effects of ergonovine. J. Psychedelic Drugs 11, 147–149 (1979)

  PubMed  CAS  Google Scholar 

• Borison, R.L., Reyes, M., Lemus, F., Havdala, H.S., Diamond, B.I.: Regional localization of 2-phenylethylamine in human brain. Res. Commun. Psych. Psychiat. Behav. 2, 193–201 (1977)

  CAS  Google Scholar 

• Braun, U., Braun, G., Jacob, P. III, Nichols, D.E., Shulgin, A.T.: Mescaline analogs: Substitutions at the 4-position. QuaSAR Research Monograph No. 22. Barnett, G., Trsic, M., Willette, R. (eds.), pp. 27–37. National Institute on Drug Abuse, U.S.G.P.O. 1978

  Google Scholar 

• Brimblecombe, R.W.: Effects of psychotropic drugs on openfield behaviour in rats. Psychopharmacologia 4, 139–147 (1963)

  Article  PubMed  CAS  Google Scholar 

• Brown, W.T., McGeer, P.L., Moser, I.: Lack of psychotomimetic effect of paramethoxy- phenethylamine and 3,4-dimethoxyphenethylamine in man. Can. Psychiat. Assoc. J. 13, 91–92 (1968)

  CAS  Google Scholar 

• Brüggemann, F., Meyer, HJ.: Die Analgetische Wirkung der Kawa-Inhaltsstoffe Dihydroka-wain und Dihydromethysticin. Arzneim. Forsch. 13, 407–409 (1963)

  Google Scholar 

• Cerletti, A.: Discussion. In: Neuropsychopharmacology. Bradley, P.B., Deniker, P., Radouco-Thomas, C. (eds.), pp. 113 - 123. Amsterdam: Elsevier 1959

  Google Scholar 

• Cerletti, A., Rothlin, E.: Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives. Nature 176, 785–786 (1955)

  Article  PubMed  CAS  Google Scholar 

• Chao, J., Der Marderosian, A.H.: Ergoline alkaloidal constituents of Hawaiian Baby Wood Rose, Argyreia nervosa (Burm. f.) Bojer. J. Pharm. Sci. 62, 588–591 (1973)

  Article  PubMed  CAS  Google Scholar 

• Chen, G., Ensor, C.R., Russell, D., Bohner, B.: The Pharmacology of l-(l-Phenylcyclohexyl)-piperidine HCl. J. Pharmacol. Exp. Ther. 127, 241–250 (1959)

  PubMed  CAS  Google Scholar 

• Chilton, W.S.: The course of an intentional poisoning. Mcllvania 2, 17–18 (1975)

  Google Scholar 

• Cimbura, G.: PMA deaths in Ontario. Can. Med. Assoc. J. 110, 1263–1267 (1974)

  PubMed  CAS  Google Scholar 

• Cook, L., Fellows, E.J.: Anorexogenic preparation and method of curbing the appitite. U.S. Patent 2,974, 148 (1961)

  Google Scholar 

• Corne, S.J., Pickering, R.W.: A possible correlation between drug-induced hallucinations in man and a behavoiral response in mice. Psychopharmacology 11, 65–78 (1967)

  Article  CAS  Google Scholar 

• Delay, J., Pichot, P., Lemperiere, T., Nicholas-Charles, P.J., Heim, R.: Effects psychophysiologique de la psilocybe. C.R. Acad. Sci. 247, 1235–1238 (1959)

  Google Scholar 

• Der Marderosian, A.H., Youngken, H.W.: The distribution of indole alkaloids among certain species and varities of Ipomoea, Rivea and Convolvulus (Convolvulacae). Lloydia 29, 35–42 (1966)

  Google Scholar 

• Der Marderosian, A.H., Pinkley, H.V., Dobbins, M.F.: Native use and occurence of N,N-di- methyltryptamine in the leaves of Banisteriopsis rusbyana. Lloydia 31, 430 (only) (1968)

  Google Scholar 

• Dittrich, A.: Alteration of behavioral changes induced by 3,4,5-trimethoxyphenylethylamine (Mescaline) by pretreatment with 2,4,5-trimethoxyphenylethylamine. A self-experiment. Psychopharmacology 21, 229–237 (1971)

  Article  CAS  Google Scholar 

• Domino, E.F., Chodoff, P., Corssen, G.: Pharmacologic effects of CI-581, a new dissociative anesthetic, in man. Clin. Pharmacol. Ther. 6, 279–291 (1965)

  PubMed  CAS  Google Scholar 

• Fabing, H.D., Hawkins, J.R.: Intravenous bufotenine injection in the human being. Science 123, 886–887 (1956)

  Article  PubMed  CAS  Google Scholar 

• Faillace, L.A., Vourlekis, A., Szara, S.: Clinical evaluation of some hallucinogenic tryptamine derivatives. J. Nerv. Ment. Dis. 145, 306–313 (1967)

  Article  PubMed  CAS  Google Scholar 

• Fairchild, M.D.: Some central nervous effects of four phenylsubstituted amphetamine derivatives. Thesis, Ph.D., Calif, U. at Los Angeles 1–147 (1963)

  Google Scholar 

• Fine, J., Finestone, S.C.: Sensory disturbances following ketamine anesthesia: Recurrent hallu-cinations. Anesth. Analg. (Cleve) 52, 428–430 (1973)

  CAS  Google Scholar 

• Fischer, E., Spatz, H., Fernândez-Labriola, R.S., Rodriguez-Casanova, E.M., Spatz, N.: Quantitative gas-chromatographic determination and infra-red spectrographic identification of urinary phenethylamines. Biol. Psychiatry 7, 161–165 (1973)

  PubMed  CAS  Google Scholar 

• Fischer, R.: Chemistry of the brain. Nature 220, 411–412 (1968)

  Article  Google Scholar 

• Friedhoff, A.J., Van Winkle, E.: Isolation and characterization of a compound from the urine of schizophrenics. Nature 194, 867–868 (1962)

  Article  Google Scholar 

• Genest, K.: A direct densitometric method on thin-layer plates for the determination of lysergic acid amide, isolysergic acid amide and clavine alkaloids in morning glory seeds. J. Chromatog. 19, 531–539 (1965)

  Article  CAS  Google Scholar 

• Gogerty, J.H., Dille, J.M.: Pharmacology of d-lysergic acid morpholide (LSM). J. Pharmacol. Exp. Ther. 120, 340–348 (1957)

  Google Scholar 

• Gorodetzky, C.W., Isbell, H.: A comparison of 2,3-dihydrolysergic acid diethylamide with LSD-25. Psychopharmacology 6, 229–233 (1964)

  Article  CAS  Google Scholar 

• Greifenstein, F.E., Devault, M., Yoshitake, J., Gajewski, J.E.: A study of 1-arylcyclohexylamine for anaesthesia. Anesth. Analg. (Cleve) 37, 283–294 (1958)

  CAS  Google Scholar 

• Grof, S., Soskin, R.A., Richards, W.A., Kurland, A.A.: DPT as an adjunct in psychotherapy of alcoholics. Int. Pharmacopsychiatry 8, 104–115 (1973)

  PubMed  CAS  Google Scholar 

• Heim, R., Wasson, R.G.: Une investigation sur les champignons sacrés des mistèques. Comptes Rend. 254, 788–791 (1962)

  Google Scholar 

• Hofmann, A.: Psychotomimetic drugs. Chemical and pharmacological aspects. Acta Physiol. Pharmacol. Neerl. 8, 240–258 (1959)

  CAS  Google Scholar 

• Hofmann, A.: The active principles of the seeds of Rivea corymbosa and Ipomoea violacea. Bot. Mus. Leafl., Harvard University 20, 194–212 (1963)

  CAS  Google Scholar 

• Hofmann, A.: Teonanacatl and Ololiuqui, two ancient magic drugs of Mexico. Bull. Narc. 23, 3–14 (1971)

  CAS  Google Scholar 

• Hollister, L.E.: Tetrahydrocannabinol isomers and homologues: Contrasted effects of smoking. Nature 227, 968–969 (1970)

  Article  PubMed  CAS  Google Scholar 

• Hollister, L.E.: Cannabidiol and Cannabinol in man. Experientia 29, 825–826 (1973)

  Article  PubMed  CAS  Google Scholar 

• Hollister, L.E., Tinklenberg, J.R.: Subchronic oral doses of Marijuana extract. Psychopharmacology 29, 247–252 (1973)

  Article  CAS  Google Scholar 

• Hollister, L.W., Prusmack, J.M., Paulsen, J.A., Rosenquist, N.: Comparison of three psychotropic drugs (Psilocybin, J.-329 and IT-290). J. Nerv. Ment. Dis. 131, 428 - 438 (1960)

  Article  PubMed  CAS  Google Scholar 

• Hsu, L.L., Mandell, A.J.: Enzymatic formation of tetrahydro-ß-carboline from tryptamine and 5-methyltetrahydrofolic acid in rat brain fractions: Regional and subcellular distribution. J. Neurochem. 24, 631–636 (1975)

  PubMed  CAS  Google Scholar 

• Hylin, J.W., Watson, D.P.: Ergoline alkaloids in tropical wood roses. Science 148, 499–500 (1965)

  Article  PubMed  CAS  Google Scholar 

• Isbell, H.: Discussions on the psychoactive actions of various tryptamine derivatives. In: Ethnopharmacologic search for psychoactive drugs. Efron, D. (ed.), pp. 374–382. U.S.G.P.O. 1967

  Google Scholar 

• Isbell, H.: Studies of tetrahydrocannabinol in man. In: Proceedings of the Meeting of the Committee on the Problems of Drug Dependence, National Academy of Sciences, National Research Council, pp. 4832–4847 (1967). vide Addendum No. 1 (1968)

  Google Scholar 

• Isbell, H., Gorodetsky, C.W., Jasinski, D., Claussen, U., v. Spulak, F., Korte, F.: Effects of (-)Δ ⁹-trans-tetrahydro-cannabinol in man. Psychopharmacology 11, 184–188 (1967)

  Article  CAS  Google Scholar 

• Iversen, L.L.: Biochemical Psychopharmacology of GAB A. In: Psychopharmacology: A Generation of Progress. Lipton, M.A., DiMascio, A., Killam, K.F., pp. 25 - 37. New York: Raven Press 1978

  Google Scholar 

• Jacobs, B.L., Trulson, M.E., Stark, A.D., Christoph, G.R.: Comparitive effects of hallucinogenic drugs on the behavior of the cat. Commun. Psychopharmacol. 1, 243–254 (1977)

  PubMed  CAS  Google Scholar 

• Jansen, M.P.J.M.: Beta-2,4,5-trimethoxyphenylethylamine, an isomer of mescaline. Rec. Trav. 25 Chim. 50, 291–312 (1931)

  Article  CAS  Google Scholar 

• Johnstone, M., Evans, V., Baigel, S.: Sernyl (CI-395) in clinical anaesthesia. Brit. J. Anaesth. 31, 433–439 (1959)

  Article  PubMed  CAS  Google Scholar 

• Kalir, A., Edery, H., Pelah, Z., Balderman, D., Porath, G.: 1-Phenylcycloalkylamine derivatives. II. Synthesis and pharmacological activity. J. Med. Chem. 12, 413–411 (1969)

  Google Scholar 

• Karnoil, I.G., Shirakawa, I., Takahashi, R.N., Knobel, E., Musty, R.E.: Effects of Δ ⁹tetrahydrocannabinol and cannabinol in man. Pharmacology 1975, 502–512

  Google Scholar 

• Keller, K.J., Elliott, G.R., Holman, J.V., Barchas, J.D.: Tryptoline inhibition of serotonin uptake in rat forebrain homogenates. J. Pharm. Exp. Ther. 198, 619–625 (1976)

  CAS  Google Scholar 

• Kelley, J.M., Adamson, R.H.: A comparison of common interatomic distances in serotonin and some hallucinogenic drugs. Pharmacology 10, 28–31 (1973)

  Article  PubMed  CAS  Google Scholar 

• Ketchum, J.S., Sidell, F.R., Crowell, E.B., Aghajanian, G.K., Hayes, A.H.: Atropine, Scopolamine, and ditran: Comparative pharmacology and antagonists in man. Psychopharmacol- ogy 28, 121–145 (1973)

  Article  CAS  Google Scholar 

• Kretzschmar, R., Meyer, H.J.: Vergleichende Untersuchungen über die Antikonvulsive der Pyronverbindungen aus Piper Methysticum Forst. Arch. Int. Pharmacodyn. Ther. 177, 261–277 (1969)

  PubMed  CAS  Google Scholar 

• Kuhn, D.M., White, F.J., Appel, J.B.: Discriminative stimulus properties of hallucinogens: Be-havioral assay of drug action. Adv. Behav. Biol. 22, 137–154 (1977)

  CAS  Google Scholar 

• Lemberger, L., Rowe, H.: Clinical pharmacology of nabilone, a cannabinol derivative. Clin. Pharmacol. Therap. 18, 720–726 (1975)

  CAS  Google Scholar 

• Leuner, H., Baer, G.: Two new short-acting hallucinogens of the psilocybin group. In: Neuropsychopharmacology. Bente, D., Bradley, P.B. (eds.), Vol.4, pp. 471–474. 1965

  Google Scholar 

• Leung, A.Y., Paul, A.G.: Baeocystin, a mono-methyl analog of psilocybin from Psilocybe baeocystis Saprophytic culture. J. Pharm. Sci. 56, 146 (only) (1967)

  Google Scholar 

• Leung, A.Y., Paul, A.G.: Bauocystin and norbaeocystin: New analogs of psilocybin from Psilocybe baeocystis. J. Pharm. Sci. 57, 1667–1671 (1968)

  Article  PubMed  CAS  Google Scholar 

• MacDougall, T.: Ipomoea tricolor, a hallucinogenic plant of the zapotecs. Bol. Cent. Invest. Antropol. Mex. 6, 6–8 (960)

  Google Scholar 

• Mclsaac, W.M.: Formation of l-methyl-6-methoxy-l,2,3,4-tetrahydro-2-carbolines under physiological conditions. Biochim. Biophys. Acta 52, 607–609 (1961)

  Article  Google Scholar 

• Meiler, E., Friedman, E., Schweitzer, J.W., Friedhoff, A.J.: Tetrahydro-ß-carbolines: Specific inhibitors of type a monoamine oxidase in rat brain. J. Neurochem. 28, 995–1000 (1977)

  Article  Google Scholar 

• Murphree, H.B., deMarr, E.W.J., Williams, H.L., Bryan, L.L.: Effects of lysergic acid derivatives on man: Antagonism between d-lysergic acid diethylamide and its 2-brom Congener. J. Pharmacol. Exp. Ther. 122, 55A–56A (1958)

  Google Scholar 

• Murphree, H.B., Jenner, E.H., Pfeiffer, C.C.: Comparison of the effects of congeners of LSD-25 and tryptophan in normal human volunteers. Pharmacologist 2, 64 (only) (1960)

  Google Scholar 

• Nakamura, G.R., Griesemer, E.C., Joiner, L.E., Noguchi, T.T.: Determination of 1-(1-Phenyl- cyclohexyl)-pyrrolidine (PHP) in postmortum specimens: a case report. Clin. Toxicol. 14, 383–388 (1979)

  Article  PubMed  CAS  Google Scholar 

• Naranjo, C.: Psychotropic properties of the harmala alkaloids. In: Ethnopharmacologic search for psychoactive drugs. Efron, D. (ed.) pp. 385–391. U.S.G.P.O. 1967

  Google Scholar 

• Naranjo, C.: Harmaline and the collective unconscious. In: The healing journey: new approaches to consciousness, pp. 124–173. New York: Pantheon Books, Random House 1973 a

  Google Scholar 

• Naranjo, C.: Ibogaine: fantasy and reality. In: The healing journey: new approaches of consciousness, pp. 174–228. New York: Pantheon Books, Random House 1973 b

  Google Scholar 

• Naranjo, C., Shulgin, A.T., Sargent, T.: Evaluation of 3,4-methylenedioxyamphetamine(MDA) as an adjunct of psychotherapy. Med. Pharmacol. Exp. 17, 359–364 (1967)

  CAS  Google Scholar 

• Ostfeld, A.M., Abood, L.G., Marcus, D.A.: Studies with ceruloplasmin and a new hallucinogen. Arch. Neurol. Psychiat. 79, 317–322 (1958)

  CAS  Google Scholar 

• Pennes, H.H., Hoch, P.H.: Psychotomimetics, clinical and theoretical considerations: Harmine, Win-2299 and Nalline. Am. J. Psychiatry 113, 887–892 (1957)

  PubMed  CAS  Google Scholar 

• Perel, A., Davidson, J.T.: Recurrent hallucinations following ketamine. Anaesthesia 31, 1081–1083 (1976)

  Article  PubMed  CAS  Google Scholar 

• Peretz, D.I., Smythies, J.R., Gibson, W.C.: A new hallucinogen: 3,4,5-trimethoxyphenyl-beta- aminopropane (with notes on a stroboscopic phenomenon). J. Ment. Sci. 101, 317–329 (1955)

  PubMed  CAS  Google Scholar 

• Perez-Reyes, M., Timmons, M.C., Lipton, M.A., Davis, K.H., Wall, E.M.: Intravenous injection in man of Δ9-tetrahydrocannabinol and 11-OH-tetrahydrocannabinol. Science 177, 633–635 (1972)

  Article  PubMed  CAS  Google Scholar 

• Perez-Reyes, M., Timmons, M.C., Davis, K.H., Wall, E.M.: A Comparison of the pharmacological activity in man of intravenously administered Δ9tetrahydrocannabinol, canna- binol, and cannabidiol. Experientia 29, 1368–1369 (1973)

  Article  PubMed  CAS  Google Scholar 

• Petersen, R.C., Stillman, R.C.: Phencyclidine (PCP) abuse: an appraisal. National Institute on Drug Abuse; Research Monograph No. 21. U.S.G.P.O. 1–313 (1978)

  Google Scholar 

• Poisson, J.: Note sur le “Natem” Boisson Toxique Péruvienne et ses Alcaloïdes. Ann. Pharm. Fr. 23, 241–244 (1965)

  PubMed  CAS  Google Scholar 

• Potkin, S.G., Karoum, F., Chuang, L.-W., Cannon-Spoor, H.E., Phillips, I., Whatt, R.J.: Phenylethylamine in paranoid chronic schizophrenia. Science 206, 470–471 (1979)

  Article  PubMed  CAS  Google Scholar 

• Rinkel, M., Atwell, C.R., Dimascio, A., Brown, J.: Experimental psychiatry. V. Psilocybine, a new psychotogenic drug. New Engl. J. Med. 262, 295–297 (1960)

  CAS  Google Scholar 

• Rothlin, E.: Lysergic acid diethylamide and related substances. Ann. N. Y. Acad. Sci. 66, 668–676 (1957)

  Article  PubMed  CAS  Google Scholar 

• Schallek, W., Smith, T.H.F.: Electroencephalographic analysis of side effects of spasmolytic drugs. J. Pharmacol. Exp. Ther. 104, 291–298 (1952)

  PubMed  CAS  Google Scholar 

• Schneider, C.W., Chenoweth, M.B.: Effects of hallucinogenic and orther drugs on the nest-building behavior of mice. Nature 225, 1262–1263 (1970)

  Article  PubMed  CAS  Google Scholar 

• Schneider, J.A., Sigg, E.B.: Pharmacologic analysis of tranquilizing and central stimulating effects. In: Psychopharmacology. Pennes, H.H. (ed.) pp. 75–98. New York: Hoeber 1958

  Google Scholar 

• Schultes, R.E.: A contribution to our knowledge of Rivea corymbosa, the narcotic ololuiqui of the aztecs pp. 15–60. Cambridge, Mass.: Botanical Mus. Leafl. Harvard University 1941

  Google Scholar 

• Shulgin, A.T.: Psychotomimetic amphetamines: Methoxy 3,4-dialkoxyamphetamines. Experientia 20, 366–367 (1964 a)

  Google Scholar 

• Shulgin, A.T.: 3-Methoxy-4,5-methylenedioxyamphetamine, a new psychotomimetic agent. Nature 201, 1120–1121 (1964b)

  Article  PubMed  CAS  Google Scholar 

• Shulgin, A.T.: Stereospecific requirements for hallucinogenesis. J. Pharm. Pharmacol. 25, 271–272 (1973)

  Article  PubMed  CAS  Google Scholar 

• Shulgin, A.T.: Psychotomimetic agents. In: Psychopharmacological Agents. Gordon, M. (ed.), Volume 4, pp. 59–146. New York: Academic Press 1976

  Google Scholar 

• Shulgin, A.T.: Psychotomimetic drugs: Structure-activity relationships. In: Handbook of Psychopharmacology. Iversen, L.L., Iversen, S.D., Snyder, S.H. (eds.), Vol. 11, pp. 243–333. New York: Plenum Press 1978

  Google Scholar 

• Shulgin, A.T.: Chemistry of phenethylamines related to mescaline. J. Psychedelic Drugs 11, 41–52 (1979)

  PubMed  CAS  Google Scholar 

• Shulgin, A.T.: Hallucinogens. In: Burger’s Medicinal Chemistry: 4th Edition. Wolfe, M.E. (ed.). New York: Wiley 1980 (in press)

  Google Scholar 

• Shulgin, A.T., Carter, M.F.: Centrally active phenethylamines. Psychopharmacol. Commun. 1, 93–98 (1975)

  PubMed  CAS  Google Scholar 

• Shulgin, A.T., Dyer, D.C.: Psychotomimetic phenylisopropylamines. V. 4-Alkyl-2,5-dimethoxyphenylisopropylamines. J. Med. Chem. 18, 1201–1204 (1975)

  CAS  Google Scholar 

• Shulgin, A.T., Nichols, D.E.: Characteristics of three new psychotomimetics. In: The psycho- pharmacology of hallucinogens. Willette, R.C., Stillman, R.E. (eds), pp. 74–83. New York: Pergamon Press 1978

  Google Scholar 

• Shulgin, A.T., Sargent, T.: Psychotropic phenylisopropylamines derived from apiole and dillapiole. Nature 215, 1494–1495 (1967)

  Article  PubMed  CAS  Google Scholar 

• Shulgin, A.T., Bunnel, S., Sargent, T.: The psychotomimetic properties of 3,4,5-trimethoxyamphetamine. Nature 189, 1011–1012 (1961)

  Article  CAS  Google Scholar 

• Shulgin, A.T., Sargent, T., Naranjo, C.: Structure-activity relationships of one ring psychotomimetics. Nature 221, 537–541 (1969)

  Article  PubMed  CAS  Google Scholar 

• Shulgin, A.T., Sargent, T., Naranjo, C.: 4-Bromo-2,5-dimethoxyphenylisopropylamine, a new centrally active amphetamine analog. Pharmacology 5, 103–107 (1971)

  Article  PubMed  CAS  Google Scholar 

• Shulgin, A.T., Sargent, T., Naranjo, C.: Animal pharmacology and human psychopharmacology of 3-methoxy-4,5-methylenedioxyphenylisopropylamine (MMDA). Pharmacology 10, 12–18 (1973)

  Article  PubMed  CAS  Google Scholar 

• Silva, M.T.A., Calil, H.M.: Screening hallucinogenic drugs: Systematic study of three behavioral tests. Psychopharmacologia 42, 163–171 (1975)

  Article  PubMed  CAS  Google Scholar 

• Sim, V.: General discussion concerning psychotomimetic drugs. In: Psychotomimetic drugs. Efron, D. (ed.), pp. 332–338. New York: Raven Press 1970

  Google Scholar 

• Slotkin, T.A., Distefano, V., Au, W.Y.W.: Blood levels and urinary excretion of harmine and its metabolites in man and rats. J. Pharmacol. Exp. Ther. 173, 26–30 (1970)

  PubMed  CAS  Google Scholar 

• Slotta, K.H., Müller, J.: Über den Abbau des Mescalins und mescalinähnlicher Stoffe im Organismus. Z. Physiol. Chem. 238, 14–22 (1963)

  Article  Google Scholar 

• Smialek, J.E., Monforte, J.R., Gault, R., Spitz, W.U.: Cyclohexamine (“Rocket Fuel”)–phencyclidine’s potent analog. J. Anal. Tox. 3, 209–212 (1979)

  CAS  Google Scholar 

• Smythies, J.R., Benington, F., Morin, R.: The mechanism of action of hallucinogenic drugs on a possible serotonin receptor in the brain. Int. Rev. Neurobiol. 72, 207–236 (1970)

  Article  Google Scholar 

• Smythies, J.R., Johnson, V.S., Bradley, R.J.: Behavioral models of psychosis. Br. J. Psychiatry 775, 55–68 (1969)

  Article  Google Scholar 

• Snyder, S.H., Merril, C.R.: A relationship between hallucinogenic activity of drugs and their electronic configuration. Proc. Natl. Acad. Sci. USA 54, 258–266 (1965)

  Article  PubMed  CAS  Google Scholar 

• Snyder, S.H., Faillace, L.A., Hollister, L.E.: 2,5-dimethoxy-4-methylamphetamine (STP): A new hallucinogenic drug. Science 158, 669–670 (1967)

  Article  PubMed  CAS  Google Scholar 

• Snyder, S.H., Faillace, L.A., Weingartner, H.: DOM (STP), a new hallucinogenic drug, and DOET: Effects in normal subjects. Am. J. Psychiatry 125, 357–364 (1968)

  Google Scholar 

• Snyder, S.H., Unger, S., Blatchley, R., Barfknecht, C.F.: Stereospecific actions of DOET (2,5-dimethoxy-4-ethylamphetamine) in man. Arch. Gen. Psychiatry 31, 103–106 (1974)

  PubMed  CAS  Google Scholar 

• Soskin, R.A., Grof, S., Richards, W.A.: Low doses of dipropyltryptamine in psychotherapy. Arch. Gen. Psychiatry 28, 817–821 (1973)

  PubMed  CAS  Google Scholar 

• Steinmetz, E.F.: Piper methysticum (Kava), pp. 3-46. Dr. E.F. Steinmetz, 347 Keizersgracht, Amsterdam, Netherlands 1960

  Google Scholar 

• Stoll, A., Hofmann, A.: Partialsynthese von Alkaloiden von Typus des Ergobasins. Helv. Chim. Acta 26, 944–965 (1943)

  Article  CAS  Google Scholar 

• Sung, M.-T., Parker, J.A.: Amphetamines; correlation of activity with stability of molecular complexes. Proc. Natl. Acad. Sci. USA 69, 1346–1347 (1972)

  Article  PubMed  CAS  Google Scholar 

• Szara, S.: Dimethyltryptamine: Its metabolism in man; the relation of its psychotic effect to the serotonin metabolism. Experientia 72, 441–442 (1956)

  Article  Google Scholar 

• Szara, S.: The comparison of the psychotic effect of tryptamine derivatives with the effects of mescaline and LSD-25 in selfexperiments. In: Psychotropic drugs. Garattini, S., Ghetti, V. (eds.), pp. 460–467. Amsterdam: Elsevier 1957

  Google Scholar 

• Szara, S., Hearst, E.: The 6-hydroxylation of tryptamine derivatives: A way to produce psychoactive metabolites. Ann. N. Y. Acad. Sci. 96, 134–141 (1962)

  Article  CAS  Google Scholar 

• Theobald, W., Büch, O., Kunz, H.A., Krupp, P., Stenger, E.G., Heimann, H.: Pharmakologische und experimentalpsychologische Untersuchungen mit 2 Inhaltsstoffen des Fliegenpilzes (Amanita Muscaria). Arzneim. Forsch. 18, 311–315 (1968)

  CAS  Google Scholar 

• Tilson, H.A., Sparber, S.B.: Similarities and differences between mescaline, lysergic acid diethylamide-25 (LSD) and d-amphetamine on various components of fixed interval responding in the rat. J. Pharmacol. Exp. Ther. 184, 376–384 (1973)

  PubMed  CAS  Google Scholar 

• Turek, I.S., Soskin, R.A., Kurland, A.A.: Methylenedioxyamphetamine subjective effects. J. Psychedelic Drugs 6, 7–14 (1974)

  Google Scholar 

• Turner, W.J., Merlis, S.: Effects of some indolealkylamines on man. Arch. Neurol. Psychiatry 81, 121–129 (1959)

  CAS  Google Scholar 

• Udenfriend, S., Witkop, B., Redfield, B.C., Weissbach, H.: Studies with reversable inhibitors of monamine oxidase: harmaline and related compounds. Biochem. Pharmacol. 7, 160–165 (1958)

  Article  Google Scholar 

• Usdin, E., Efron, D.H.: (from literature supplied by Sandoz Pharmaceuticals, Hanover, N.J.), vide: Psychotropic Drugs and Related Compounds. U.S.G.P.O., 94 only (1972 a)

  Google Scholar 

• Usdin, E., Efron, D.H.: (from literature supplied by Sandoz Pharmaceuticals, Hanover, N.J.), vide: Psychotropic Drugs and Related Compounds. U.S.G.P.O., 101 only (1972b)

  Google Scholar 

• Usdin, E., Efron, D.H.: (from literature supplied by Sandoz Pharmaceuticals, Hanover, N.J.), vide: Psychotropic Drugs and Related Compounds. U.S.G.P.O., 102 only (1972c)

  Google Scholar 

• Vincent, D., Sero, J.: Action inhibitrice de Tabernanthe iboga sur la cholinestérase du sérum. C.R. Soc. Biol. 136, 612–614 (1942)

  CAS  Google Scholar 

• Vojtěchovský, M., Krus, D.: Psychotropic effects of mescalinelike drugs. Acta Nerv. Sup. 1967, 381–383

  Google Scholar 

• Vojtěchovský, M., Vitec, V., Rysânek, K., Bultasovâ, H.: Psychotogenic and hallucinogenic properties of large doses of benactyzine. Experientia 14, 422–423 (1958)

  Article  PubMed  Google Scholar 

• Wall, M.E., Brine, D.R., Perez-Reyes, M.: Metabolism of cannabinoids in man. In: The phar-macology of marihuana. Braunde, M.C., Szara, S. (eds.), pp. 93–116. New York: Raven Press 1976

  Google Scholar 

• Waser, P.G.: The pharmacology of Amanita muscaria. In: Ethnopharmacologic search for psy-choactive Drugs. Efron, D.H. (ed.), pp. 419–439. U.S.G.P.O. 1967

  Google Scholar 

• Williams, E.G., Himmelsbach, C.K., Wikler, A., Ruble, D.C., Lloyd, B.J., Jr.: Studies on marihuana and pyrahexyl compound. Public Health Rep. 61, 1059–1083 (1946)

  Article  PubMed  CAS  Google Scholar 

• Wolbach, A.B., Miner, E.J., Isbell, H.: Comparison of psilocin with psilocybin, mescaline, and LSD-25. Psychopharmacologia 3, 219–223 (1962)

  Article  PubMed  CAS  Google Scholar 

• Wyatt, R.J., Erdelyi, E., Doamaral, J.R., Elliott, G.R., Renson, J., Brachas, J.D.: Tryptoline formation by a preparation from brain with 5-methyltetrahydrofolic acid and tryptamine. Science 187, 853–855 (1975)

  Article  PubMed  CAS  Google Scholar 

• Yensen, I.S., Dileo, F.B., Rhead, J.C., Richards, W.A., Soskin, R.A., Turik, B., Kurland, A.A.: MDA-assisted psychotherapy with neurotic outpatients: a pilot study. J. Nerv. Ment. Dis. 163, 233–245 (1976)

  Article  PubMed  CAS  Google Scholar 

• Zweig, J.S., Castagnoli, N.: Chemical conversion of the psychotomimetic amine l-(2,5-di- methoxy-4-methylphenyl)-2-aminopropane to 5-hydroxy-2,6-dimethylindole. J. Med. Chem. 17, 747–749 (1974)

  Article  PubMed  CAS  Google Scholar 

• Zweig, J.S., Castagnoli, N.: Metabolic O-demethylation of the psychotomimetic amine l-(2,5- dimethoxy-4-methylphenyl)-2-aminopropane. Commun. Psychopharmacol. 1, 359–371 (1975)

  CAS  Google Scholar 

Download references

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.4